Nanoscale structures have been at the core of research efforts dealing with integration of
nanotechnology into novel electronic devices for the last decade. Because the size of …

In recent decades, research scientists, molecular biologists, and pharmacologists have
placed a strong emphasis on cutting-edge nanostructured materials technologies to …

Neurons and their connecting axons gradually degenerate in neurodegenerative diseases
(NDs), leading to dysfunctionality of the neuronal cells and eventually their death. Drug …

Nanomaterials (NMs) are receiving remarkable attention due to their unique properties and
structure. They vary from atoms and molecules along with those of bulk materials. They can …

Therapies directed toward the central nervous system remain difficult to translate into
improved clinical outcomes. This is largely due to the blood–brain barrier (BBB), arguably …

Central nervous system (CNS) disorders especially neurodegenerative disorders are the
major challenge for public health and demand the great attention of researchers to protect …

The blood–brain barrier is the interface between the blood and brain, impeding the passage
of most circulating cells and molecules, protecting the latter from foreign substances, and …

Central nervous system disorders, especially neurodegenerative diseases, are a public
health priority and demand a strong scientific response. Various therapy procedures have …

Nanotechnologies are materials and devices that have a functional organization in at least
one dimension on the nanometer (one billionth of a meter) scale, ranging from a few to …

The major neurological disorders found in a central nervous system (CNS), such as brain
tumors, Alzheimer's diseases, Parkinson's diseases, and Huntington's disease, have led to …